Lower macrophage migration inhibitory factor concentrations in maternal serum before pre-eclampsia onset

Journal of Interferon and Cytokine Research

Volumn 34, Issue 7, 2014, Pages 537-542

  Cardaropoli, Simona ^a,b   Ietta, Francesca ^c   Romagnoli, Roberta ^c   Rolfo, Alessandro ^b   Paulesu, Luana ^c   Todros, Tullia ^a,b  

^a S ANNA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; STANDARD;

ADULT; FEMALE; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE STANDARDS;

EID: 84903766422     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0057     Document Type: Article

References (40)

1. Aloisi AM, Pari G, Ceccarelli I, Vecchi I, Ietta F, Lodi L, Paulesu L. 2005. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 115:142-151.
2. American College of Obstetricians and Gynecologists Criteria. 2002. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99:159-167.
3. Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L. 1999. Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod 60:1299-1303. (Pubitemid 29240911)
4. Audibert F, Friedman SA, Frangieh AY, Sibai BM. 1996. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 175:460-464. (Pubitemid 26391008)
5. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC, et al. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150:235-246. (Pubitemid 27027113)
6. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 93:7849-7854. (Pubitemid 26277127)
7. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759. (Pubitemid 23339882)
8. Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, Gilli G, Bona G, Fabris C, De Curtis M, et al. 2010. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr 51:353-361.
9. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, Mandel S, Rabinovitch L, Paltieli Y, Admon A, et al. 2004. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 25:608-622. (Pubitemid 38950314)
10. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. 1995. MIF as a glucocor-ticoid-induced modulator of cytokine production. Nature 377:68-71.
11. Calandra T, Bernhagen J, Mitchell RA, Bucala R. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-1902. (Pubitemid 24155670)
12. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hültner L, Heumann D, Männel D, Bucala R, Glauser MP. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6:164-170. (Pubitemid 30082360)
13. Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800. (Pubitemid 37328657)
14. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Ku-liszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105:577-587. (Pubitemid 30146504)
15. Cardaropoli S, Paulesu L, Romagnoli R, Ietta F, Marzioni D, Castellucci M, Rolfo A, Vasario E, Piccoli E, Todros T. 2012. Macrophage migration inhibitory factor in fetopla-cental tissues from preeclamptic pregnancies with or without fetal growth restriction. Clin Dev Immunol 2012:639342.
16. Clark P, Boswell F, Greer IA. 1998. The neutrophil and pre-eclampsia. Semin Reprod Endocrinol 16:57-64.
17. Conrad KP, Benyo DF. 1997. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37:240-249. (Pubitemid 27149786)
18. Duckitt K, Harrington D. 2005. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565.
19. Duley L. 2009. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33:130-137.
20. Grieb G, Merk M, Bernhagen J, Bucala R. 2010. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 23:257-264.
21. Hirokawa J, Sakaue S, Tagami S, Kawakami Y, Sakai M, Nishi S, Nishihira J. 1997. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. Biochem Biophys Res Commun 235:94-98. (Pubitemid 27302691)
22. Hristoskova S, Holzgreve W, Zhong XY, Hahn S. 2006. Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia. Arch Gynecol Obstet 274:25-28.
23. Huppertz B. 2008. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51:970-975. (Pubitemid 351398986)
24. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Paulesu L. 2002. Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 48:404-409. (Pubitemid 35469292)
25. Ietta F, Wu Y, Romagnoli R, Soleymanlou N, Orsini B, Za-mudio S, Paulesu L, Caniggia I. 2007. Oxygen regulation of macrophage migration inhibitory factor in human placenta. Am J Physiol Endocrinol Metab 292:E272-E280. (Pubitemid 46052950)
26. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M. 2000. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397-403.
27. Ortiz-Barahona A, Villar D, Pescador N, Amigo J, del Peso L. 2010. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res 38:2332-2345.
28. Pearce BD, Garvin SE, Grove J, Bonney EA, Dudley DJ, Schendel DE, Thorsen P. 2008. Serum macrophage migration inhibitory factor in the prediction of preterm delivery. Am J Obstet Gynecol 199:46.e1-e6.
29. Pearce BD, Grove J, Bonney EA, Bliwise N, Dudley DJ, Schendel DE, Thorsen P. 2010. Interrelationship of cyto-kines, hypothalamic-pituitary-adrenal axis hormones, and psychosocial variables in the prediction of preterm birth. Gynecol Obstet Invest 70:40-46.
30. Redman CW, Sacks GP, Sargent IL. 1999. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499-506. (Pubitemid 29093892)
31. Redman CW, Sargent IL. 2005. Latest advances in understanding preeclampsia. Science 308:1592-1594. (Pubitemid 40807500)
32. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang J, Post M, Caniggia I. 2010. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 5:e13288.
33. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G. 2011. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothe-lial progenitor cell recruitment. J Cell Mol Med 15:668-678.
34. Todros T, Bontempo S, Piccoli E, Ietta F, Romagnoli R, Biol-cati M, Castellucci M, Paulesu L. 2005. Increased levels of macrophage migration inhibitory factor (MIF) in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 123:162-166. (Pubitemid 41728359)
35. von Dadelszen P, Magee LA, Roberts JM. 2003. Subclassification of preeclampsia. Hypertens Pregnancy 22:143-148. (Pubitemid 37521365)
36. Wada S, Fujimoto S, Mizue Y, Nishihira J. 1997. Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells. Bio-chem Mol Biol Int 41:805-814. (Pubitemid 27182714)
37. Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, et al. 1997. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 94: 4782-4787. (Pubitemid 27194321)
38. Wymann D, Blüggel M, Kalbacher H, Blesken T, Akdis CA, Meyer HE, Blaser K. 1999. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif. Immunology 96:1-9. (Pubitemid 29030574)
39. Yamada H, Kato EH, Morikawa M, Shimada S, Saito H, Watari M, Minakami H, Nishihira J. 2003. Decreased serum levels of macrophage migration inhibition factor in miscarriages with normal chromosome karyotype. Hum Reprod 18:616-620. (Pubitemid 36329335)
40. Zhong Y, Tuuli M, Odibo AO. 2010. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 30:293-308.